Who owns BeOne Medicines (ONC)? Superinvestor holders
6 superinvestors of the 157 tracked here hold BeOne Medicines (ONC) in their latest 13F filing, with $5B between them. Julian and Felix Baker gives it the most weight: 12.6% of the reported portfolio.
Zhang Lei sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 6 of 157
- Biggest holder
- Julian and Felix Baker, $2.5B
- Largest weight
- Julian and Felix Baker, 12.6%of their portfolio
- Combined value
- $5B
- Bought last quarter
- 4
- Sold last quarter
- 3
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Julian and Felix BakerBaker Bros. Advisors | 12.6% | $2.5B | 8.8M | ▲ Added 0.03% | +2.64K | Q2 2026 |
| 2 | Primecap teamPrimecap Management | 1.11% | $1.8B | 4.91M | ▼ Reduced 2.0% | −101.16K | Q3 2026 |
| 3 | Ken GriffinCitadel Advisors | 0.23% | $406.2M | 1.43M | ▲ Added 38% | +393.21K | Q2 2026 |
| 4 | Sarah KettererCauseway Capital Management | 0.22% | $19.8M | 54.03K | New | +54.03K | Q3 2026 |
| 5 | TemasekTemasek Holdings | 0.21% | $75.2M | 205.47K | ▼ Reduced 76% | −640.42K | Q3 2026 |
| 6 | John Overdeck and David Siegel (founders)Two Sigma Investments | 0.18% | $240.3M | 656.71K | ▲ Added 129% | +370.16K | Q3 2026 |
Sold out last quarter
- Zhang Leiwas $307.2M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 4 | 5.82M | $2.1B | 2 | 2 |
| Q2 2026 | 157 | 4 | 16.08M | $4.6B | 3 | 2 |
| Q1 2026 | 157 | 6 | 16.7M | $5B | 1 | 2 |
| Q4 2025 | 157 | 5 | 15.73M | $4.8B | 0 | 2 |
| Q3 2025 | 157 | 5 | 15.93M | $5.4B | 1 | 3 |
| Q2 2025 | 157 | 6 | 16.16M | $3.9B | 2 | 4 |
| Q1 2025 | 156 | 8 | 20.85M | $5.7B | 1 | 5 |
| Q4 2024 | 156 | 7 | 23.99M | $4.4B | 1 | 4 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Primecap team | 4.91M | 5.01M | 4.98M | 4.98M | 5.08M | 5.09M | 5.06M | 5.1M |
| John Overdeck and David Siegel (founders) | 656.71K | — | — | — | — | — | — | — |
| Temasek | 205.47K | 845.73K | 862.64K | 919.59K | 1.01M | 1.01M | 993.75K | 1.53M |
| Sarah Ketterer | 54.03K | — | — | — | — | — | — | — |
| Julian and Felix Baker | · | 8.8M | 8.8M | 8.8M | 8.8M | 8.8M | 8.8M | 9.53M |
| Ken Griffin | · | 1.43M | 1.03M | — | — | — | 982.16K | — |
| Zhang Lei | · | — | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 3.8M |
| Andrew Spokes | — | — | 1.1K | 1.1K | 1.1K | 1.1K | 1.1K | 1.1K |
| Saudi Public Investment Fund | — | — | — | — | — | 227.18K | 354.39K | 354.39K |
| Baillie Gifford team | — | — | — | — | — | — | 3.63M | 3.67M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own ONC?
In their latest 13F filings: Julian and Felix Baker (12.6% of the portfolio, $2.5B), Primecap team (1.11% of the portfolio, $1.8B), Ken Griffin (0.23% of the portfolio, $406.2M), Sarah Ketterer (0.22% of the portfolio, $19.8M), Temasek (0.21% of the portfolio, $75.2M), John Overdeck and David Siegel (founders) (0.18% of the portfolio, $240.3M).
Who bought ONC last quarter?
Julian and Felix Baker (added 0.0%), Ken Griffin (added 38%), Sarah Ketterer (new position), John Overdeck and David Siegel (founders) (added 129%). “Last quarter” is each investor's latest reported quarter.
Who sold ONC last quarter?
Reduced: Primecap team (2.0% fewer shares), Temasek (76% fewer shares). Sold out entirely: Zhang Lei (was $307.2M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns BeOne Medicines (ONC)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ONC/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ONC by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.